200 related articles for article (PubMed ID: 34163592)
1. Ultrasensitive small molecule fluorogenic probe for human heparanase.
Liu J; Schleyer KA; Bryan TL; Xie C; Seabra G; Xu Y; Kafle A; Cui C; Wang Y; Yin K; Fetrow B; Henderson PKP; Fatland PZ; Liu J; Li C; Guo H; Cui L
Chem Sci; 2020 Oct; 12(1):239-246. PubMed ID: 34163592
[TBL] [Abstract][Full Text] [Related]
2. An ultrasensitive FRET-based fluorescent low molecular weight heparin nanoprobe for quantifying heparanase activity.
Gu Y; Peng L; Ding W; Wang Y; Zeng X
Talanta; 2023 Mar; 254():124207. PubMed ID: 36549136
[TBL] [Abstract][Full Text] [Related]
3. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
4. A Universal and Modular Scaffold for Heparanase Activatable Probes and Drugs.
Schleyer KA; Liu J; Chen Z; Wang Z; Zhang Y; Zuo J; Ybargollin AJ; Guo H; Cui L
Bioconjug Chem; 2022 Dec; 33(12):2290-2298. PubMed ID: 36346913
[TBL] [Abstract][Full Text] [Related]
5. Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications.
Vlodavsky I; Elkin M; Ilan N
Rambam Maimonides Med J; 2011 Jan; 2(1):e0019. PubMed ID: 23908791
[TBL] [Abstract][Full Text] [Related]
6. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
7. Heparanase: a target for drug discovery in cancer and inflammation.
McKenzie EA
Br J Pharmacol; 2007 May; 151(1):1-14. PubMed ID: 17339837
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
9. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Vlodavsky I; Ilan N; Naggi A; Casu B
Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
[TBL] [Abstract][Full Text] [Related]
10. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
11. The potential of heparanase as a therapeutic target in cancer.
Pisano C; Vlodavsky I; Ilan N; Zunino F
Biochem Pharmacol; 2014 May; 89(1):12-9. PubMed ID: 24565907
[TBL] [Abstract][Full Text] [Related]
12. Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.
Goodall KJ; Poon IK; Phipps S; Hulett MD
PLoS One; 2014; 9(10):e109596. PubMed ID: 25295599
[TBL] [Abstract][Full Text] [Related]
13. Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events.
Masola V; Bellin G; Gambaro G; Onisto M
Cells; 2018 Nov; 7(12):. PubMed ID: 30487472
[TBL] [Abstract][Full Text] [Related]
14. Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.
Schoenfeld AK; Vierfuß S; Lühn S; Alban S
J Pharm Biomed Anal; 2014 Jul; 95():130-8. PubMed ID: 24667567
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.
Dai X; Yan J; Fu X; Pan Q; Sun D; Xu Y; Wang J; Nie L; Tong L; Shen A; Zheng M; Huang M; Tan M; Liu H; Huang X; Ding J; Geng M
Clin Cancer Res; 2017 Oct; 23(20):6267-6278. PubMed ID: 28710312
[No Abstract] [Full Text] [Related]
16. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
[TBL] [Abstract][Full Text] [Related]
17. Development of heparanase inhibitors for anti-cancer therapy.
Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
[TBL] [Abstract][Full Text] [Related]
18. Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts.
Sotnikov I; Hershkoviz R; Grabovsky V; Ilan N; Cahalon L; Vlodavsky I; Alon R; Lider O
J Immunol; 2004 May; 172(9):5185-93. PubMed ID: 15100255
[TBL] [Abstract][Full Text] [Related]
19. Heparanase and the hallmarks of cancer.
Jayatilleke KM; Hulett MD
J Transl Med; 2020 Nov; 18(1):453. PubMed ID: 33256730
[TBL] [Abstract][Full Text] [Related]
20. Polymeric fluorescent heparin as one-step FRET substrate of human heparanase.
Sistla JC; Morla S; Alabbas AB; Kalathur RC; Sharon C; Patel BB; Desai UR
Carbohydr Polym; 2019 Feb; 205():385-391. PubMed ID: 30446119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
